Mundipharma And Egis Partner For Pelmeg In Four CEE Markets

 
• By Akriti Seth

Mundipharma is entering into a partnership with Egis for launching its pegfilgrastim biosimilar treatment in Hungary, Romania, Latvia and Lithuania.

Magnified_Map
Mundipharma targets Central and Eastern European markets • Source: Shutterstock

More from Deals

More from Business